Correlation Between Acumen Pharmaceuticals and Unity Biotechnology
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Unity Biotechnology, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Unity Biotechnology.
Diversification Opportunities for Acumen Pharmaceuticals and Unity Biotechnology
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Acumen and Unity is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Unity Biotechnology go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Unity Biotechnology
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Unity Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 1.05 times less risky than Unity Biotechnology. The stock trades about -0.02 of its potential returns per unit of risk. The Unity Biotechnology is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 393.00 in Unity Biotechnology on December 1, 2024 and sell it today you would lose (222.00) from holding Unity Biotechnology or give up 56.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Unity Biotechnology
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Unity Biotechnology |
Acumen Pharmaceuticals and Unity Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Unity Biotechnology
The main advantage of trading using opposite Acumen Pharmaceuticals and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |